| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |